The case involves the Corporate Insolvency Resolution Process (CIRP) of Ayurwin Pharma Private Limited. The CIRP was initiated based on a petition under Section 9 of the Insolvency and Bankruptcy Code (IBC), 2016. Ms. Shirley Mathew was appointed as the Resolution Professional (RP). Several applications were filed, including I.A. No.523/2020 for early dissolution, I.A. No.524/2020 for the sale of assets, and I.A. No.328/2020 for liquidation. The Committee of Creditors (CoC) initially consisted of Corporation Bank, later reconstituted with the inclusion of IndusInd Bank. The RP sought directions for the dissolution of the Corporate Debtor due to the insufficiency of assets to cover liquidation costs and the lack of prospects for revival.
The Corporate Debtor, Ayurwin Pharma Private Limited, underwent CIRP following an application under Section 9 of the IBC. Ms. Shirley Mathew served as the Resolution Professional. The CIRP was initiated due to the company's financial distress, with operations ceasing in March 2017. The admitted claims of financial and operational creditors totaled Rs.87,04,06,564/-, while the realizable assets were only Rs.24,28,600/-. The Committee of Creditors (CoC) initially comprised Corporation Bank, later including IndusInd Bank. Valuation reports indicated minimal liquidation value for the Corporate Debtor's assets. The CoC unanimously resolved to sell the assets and dissolve the company. The last available audited financial statements were for the year 2014-15. The Corporate
…Sign in to view the parties.
The petition seeking…
The last date for…
The case involves the Corporate Insolvency Resolution Process (CIRP) of Ayurwin Pharma Private Limited. The CIRP was initiated based on a petition under Section 9 of the Insolvency and Bankruptcy Code (IBC), 2016. Ms. Shirley Mathew was appointed as the Resolution Professional (RP). Several applications were filed, including I.A. No.523/2020 for early dissolution, I.A. No.524/2020 for the sale of assets, and I.A. No.328/2020 for liquidation. The Committee of Creditors (CoC) initially consisted of Corporation Bank, later reconstituted with the inclusion of IndusInd Bank. The RP sought directions for the dissolution of the Corporate Debtor due to the insufficiency of assets to cover liquidation costs and the lack of prospects for revival.
The Corporate Debtor, Ayurwin Pharma Private Limited, underwent CIRP following an application under Section 9 of the IBC. Ms. Shirley Mathew served as the Resolution Professional. The CIRP was initiated due to the company's financial distress, with operations ceasing in March 2017. The admitted claims of financial and operational creditors totaled Rs.87,04,06,564/-, while the realizable assets were only Rs.24,28,600/-. The Committee of Creditors (CoC) initially comprised Corporation Bank, later including IndusInd Bank. Valuation reports indicated minimal liquidation value for the Corporate Debtor's assets. The CoC unanimously resolved to sell the assets and dissolve the company. The last available audited financial statements were for the year 2014-15. The Corporate
…The petition seeking…
The last date for…